logo

TMDX

TransMedics Group·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

TMDX fundamentals

TransMedics Group (TMDX) released its earnings on Oct 29, 2025: revenue was 143.80M (YoY +32.17%), missed estimates; EPS was 0.66 (YoY +450.00%), beat estimates.
Revenue / YoY
143.80M
+32.17%
EPS / YoY
0.66
+450.00%
Report date
Oct 29, 2025
TMDX Earnings Call Summary for Q3,2025
  • Revenue Surge: Q3 2025 revenue up 32.2% YoY to $143.8M, driven by 41% liver growth and 35% logistics expansion.
  • Gross Margin Expansion: 59% gross margin (up 2.9% YoY), fueled by fleet utilization and cost efficiencies.
  • Global Ambitions: Italy NOP launch in H1 2026, with European and international expansion underway.
  • Clinical Catalysts: ENHANCE/DENOVO trials to enroll first patients in Q4, with potential 2026 OCS adoption boost.
  • Operational Efficiency: 22 aircraft fleet, 78% NOP coverage, and double-shifting pilot to optimize costs.
  • Kidney Program: Design unveiling in early 2026, targeting CMS cost savings and 23,000+ kidney transplants annually.
  • Financial Strength: $466M cash, 16% operating margin (vs. 4% YoY), and $24M net income.
  • Long-Term Vision: 10,000+ annual transplants by 2028, 30% operating margin by 2028, and Gen 3 OCS platform development.
EPS
Revenue

Revenue & Expenses

TMDX has released its 2025 Q3 earnings report, with revenue of 143.82M, reflecting a YoY change of 32.24%, and net profit of 24.32M, showing a YoY change of 476.83%. The Sankey diagram below clearly presents TMDX's revenue sources and cost distribution.

Key Indicators

TransMedics Group (TMDX) key financial stats and ratios, covering profitability, financial health, and leverage.
TransMedics Group (TMDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
TransMedics Group (TMDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
TransMedics Group (TMDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does TransMedics Group (TMDX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track TransMedics Group (TMDX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield